Cuprizone-induced Demyelination in Mouse Brain is not due to Depletion of Copper
ASN Neuro · 2022-01 · 14 (1)
DOI: 10.1177/17590914221126367 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASN Neuro, online erschienen am 16.09.2022. Verfasst von Megan L Morgan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cumming School of Medicine, Department of Clinical Neurosciences, University of Calgary, Hotchkiss Brain Institute, Calgary, 3330 Hospital Drive N.W.…. Hauptthemen laut MEDLINE: Cuprizone, Demyelinating Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Multiple Sclerosis Society of Canada, Canada Research Chairs.
Abstract (Originalsprache)
The cuprizone (CPZ) model allows the study of the biochemical processes underlying nonautoimmune-mediated demyelination, remyelination, and chronic white matter disease progression. CPZ is a copper (Cu) chelator that chiefly causes oligodendrocyte apoptosis in the corpus callosum and cerebellum when administered in the mouse diet. While disruption of Cu homeostasis is known to cause neurodegeneration (as is observed in Wilson’s and Menkes disease), no consensus exists to date as to CPZ’s mechanism of action. We sought to determine whether CPZ-induced pathology is due to Cu depletion as is generally believed. Cu supplementation in chow, in stoichiometric excess to the added CPZ, did not reduce CPZ-induced demyelination in C57Bl/6 mice. Moreover, equivalent doses of other known Cu chelators neocuproine and D-penicillamine (D-Pen) failed to induce central nervous system (CNS) demyelination. Since administration of D-Pen in the treatment of Wilson’s disease can induce hypocupremia, we next sought to recreate penicillamine-induced Cu deficiency to compare with purported CPZ-induced Cu deficiency. The resulting clinical phenotype and histopathology were unlike that of CPZ. D-Pen-treated mice exhibited digit paralysis, tail flaccidity, subcutaneous hemorrhaging, and optic and sciatic neuropathy, all of which were prevented with Cu supplementation. No demyelination of the corpus callosum or cerebellum was observed, even with D-Pen doses tenfold higher than CPZ. Intriguingly, addition of D-Pen to the CPZ diet paradoxically prevented demyelination in a dose-dependent manner. Summary StatementThe demyelinating effects of CPZ are not due to Cu deficiency but are instead consistent with acute toxicity of a CPZ + Cu complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cumming School of Medicine, Department of Clinical Neurosciences, University of Calgary, Hotchkiss Brain Institute, Calgary, 3330 Hospital Drive N.W. HRIC 1B37A, Calgary, AB, T2N 4N1, Canada.
ORCID-Profile: Megan L Morgan
Förderung
- CIHR
- Multiple Sclerosis Society of Canada
- Canada Research Chairs
- Canadian Institutes for Health Research
Zitieren
APA
Morgan, M. L., Teo, W., Hernandez, Y., Brideau, C., Cummins, K., Kuipers, H. F., & Stys, P. K. (2022). Cuprizone-induced Demyelination in Mouse Brain is not due to Depletion of Copper. ASN Neuro, 14(1). https://doi.org/10.1177/17590914221126367
Vancouver
Morgan ML, Teo W, Hernandez Y, Brideau C, Cummins K, Kuipers HF, et al. Cuprizone-induced Demyelination in Mouse Brain is not due to Depletion of Copper. ASN Neuro. 2022;14(1). doi:10.1177/17590914221126367
BibTeX
@article{Morgan2022,
author = {Morgan, Megan L and Teo, Wulin and Hernandez, Yda and Brideau, Craig and Cummins, Karen and Kuipers, Hedwich F and Stys, Peter K},
title = {Cuprizone-induced Demyelination in Mouse Brain is not due to Depletion of Copper},
journal = {ASN Neuro},
year = {2022},
volume = {14},
number = {1},
doi = {10.1177/17590914221126367}
}
EUVIMED